Abstract
New Schiff’s base derivatives 5a–j have been synthesized by reaction between 5-aryloxypyrazole-4-carbaldehydes 3a–j and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetohydrazide 4 in the presence of nickel (II) nitrate as a catalyst in ethanol at room temperature with good yield (75–88 %). All compounds were tested for antibacterial properties and inhibition of E. coli FabH. Of the compounds studied, the majority of the compounds showed effective antibacterial properties and inhibition of E. coli FabH activity. Compound 5i showed the most effective inhibition (IC50 = 4.6 ± 0.2 µM) by binding into the active site of the E. coli FabH receptor with minimum binding energy (ΔG b = −54.2961 kcal/mol). The binding was stabilized by two hydrogen bonds, two π–π, and three π–cation interactions.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11164-015-2018-1/MediaObjects/11164_2015_2018_Sch1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11164-015-2018-1/MediaObjects/11164_2015_2018_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11164-015-2018-1/MediaObjects/11164_2015_2018_Fig2_HTML.jpg)
Similar content being viewed by others
References
N. Woodford, Drugs 12, 117 (2003)
Z.L. Li, Q.S. Li, H.J. Zhang, Y. Hu, D.D. Zhu, H.L. Zhu, Bioorg. Med. Chem. 19, 4413 (2011)
J.Y. Lee, K.W. Jeong, J.U. Lee, D.I. Kang, Y. Kim, Bioorg. Med. Chem. 17, 5408 (2009)
H.J. Zhang, Z.L. Li, H.L. Zhu, Curr. Med. Chem. 19, 1225 (2012)
S.S. Khandekar, R.A. Daines, J.T. Lonsdale, Curr. Protein Pept. Sci. 4, 21 (2003)
J.T. Tsay, W. Oh, T.J. Larson, S.J. Jakowski, Biol. Chem. 267, 6807 (1992)
R.J. Heath, C.O. Rock, J. Biol. Chem. 271, 1833 (1996)
C.E. Christensen, B.B. Kragelund, P. von Wettstein-Knowles, A. Henriksen, Protein Sci. 16, 261 (2007)
H.Q. Li, L. Shi, Q.S. Li, P.C. Lv, Y. Luo, H.L. Zhu, Bioorg. Med. Chem. 20, 6264 (2009)
R. Puupponen-Pimia, L. Nohynek, C. Meier, M. Kahkonen, M. Heinonen, A. Hopia, K.M. Oksman-Caldentey, J. Appl. Microbiol. 90, 494 (2001)
Y. Luo, L.R. Zhang, Y. Hu, S. Zhang, J. Fu, X.M. Wang, H.L. Zhu, Chem. Med. Chem. 7, 1587 (2012)
V. Brusic, N. Petrovsky, Exp. Rev. Clin. Immunol. 1, 145 (2005)
Y. Uto, H. Nagasawa, C.Z. Jin, S. Nakayama, A. Tanaka, S. Kiyoi, H. Nakashima, M. Shimamura, S. Inayama, T. Fujiwara, Y. Takeuchi, Y. Uehara, K.L. Kirk, E. Nakata, H. Hori, Bioorg. Med. Chem. 16, 6042 (2008)
Y. Luo, H.Q. Li, Y. Zhou, Z.L. Li, T. Yan, H.L. Zhu, Chem. Med. Chem. 5, 1117 (2010)
A. Boza, R. Gonzalez, H. Novoa, D.M. Cuéllar, M. Valdés, IL Farmaco 55, 700 (2000)
K. Soedin, O. Syukran, A. Fadillah, P. Sidabutar, Pharmaceutica 4, 251 (1985)
H.J. Zhang, X. Qin, K. Liu, D.D. Zhu, X.M. Wang, H.L. Zhu, Bioorg. Med. Chem. 19, 5708 (2011)
J.Y. Lee, K.W. Jeong, J.U. Lee, D.I. Kang, Y. Kim, Bioorg. Med. Chem. 17, 1506 (2009)
Y. Li, C.P. Zhao, H.P. Ma, M.Y. Zhao, Y.R. Xue, X.M. Wang, H.L. Zhu, Bioorg. Med. Chem. 21, 3120 (2013)
P.C. Lv, J. Sun, Y. Luo, Y. Yang, H.L. Zhu, Bioorg. Med. Chem. Lett. 20, 4657 (2010)
C.B. Sangani, D.C. Mungra, M.P. Patel, R.G. Patel, Chin. Chem. Lett. 23, 57 (2012)
X. He, A.M. Reeve, U.R. Desai, G.E. Kellogg, K.A. Reynolds, Antimicrob. Agents Chemother. 48, 3093 (2004)
L.X. Zhang, Y. Liu, L.H. Cia, Y.J. Hu, J. Yin, P.Z. Hu, Thermochim. Acta 440, 51 (2006)
N. Sirisoma, A. Pervin, J. Drewe, B. Tseng, S.X. Cai, Bioorg. Med. Chem. Lett. 19, 2710 (2009)
Z. Li, Z. Gu, K. Yin, R. Zhang, Q. Deng, J. Xiang, Eur. J. Med. Chem. 44, 4716 (2009)
S.D. Jorge, A. Masunari, C.O. Rangel-Yagui, K.F.M. Pasqualoto, L.C. Tavares, Bioorg. Med. Chem. 17, 3028 (2009)
J.A. Makawana, J. Sun, H.L. Zhu, Bioorg. Med Chem. Lett. 23, 6264 (2013)
J. Mirzaei, M. Amini, H. Pirelahi, A.J. Shafiee, Heterocycl. Chem. 45, 921 (2008)
Acknowledgments
The work was financed by National Natural Science Foundation of China (No. J1103512).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Sangani, C.B., Makwana, J.A., Duan, YT. et al. Design, synthesis, and antibacterial evaluation of new Schiff’s base derivatives bearing nitroimidazole and pyrazole nuclei as potent E. coli FabH inhibitors. Res Chem Intermed 41, 10137–10149 (2015). https://doi.org/10.1007/s11164-015-2018-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-015-2018-1